Characterization of Insoluble Subvisible Particles in Biopharmaceuticals by Flow Imaging Method

In characterization of insoluble subvisible particulate matter in biopharmaceuticals, particles with sizes of 10 μm and larger are characterized by the light obscuration (LO) method as a test method in the Japanese and United States Pharmacopoeias (JP and USP). However, in recent years it has been reported that the LO method has poor sensitivity for highly transparent particles (e.g. aggregates of proteins) in comparison with the flow imaging (FI) method. As an additional limitation of LO, it is also impossible to predict the type of particle from the particle image in some cases.
This article introduces an example of characterization of the concentration of insoluble subvisible particles of micrometer-order size in a protein solution by using a Shimadzu iSpect DIA-10, which is based on the flow imaging method.

Content Type:
Document Number:
Product Type:
Particle Size Analysis
Biopharmaceuticals, antibody drugs, drugs, injection preparations, pharmaceutical, proteins, aggregates, foreign object detection, concentration measurement, particle analysis, particle image, image evaluation, flow imaging method, DIA, flow imaging method, FI, light obscuration method, LO, pharmacopoeia, JP, USP, FDA, Pharmaceutical, Life Science, iSpect DIA-10
File Name:
File Size:

Free Download

For Research Use Only. Not for use in diagnostic procedures.

This page may contain references to products that are not available in your country. Please contact us to check the availability of these products in your country.

Top of This Page